229 related articles for article (PubMed ID: 23636152)
1. Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.
Rosser S; Frede S; Conrad WF; Heaton PC
J Am Pharm Assoc (2003); 2013; 53(1):22-9. PubMed ID: 23636152
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting.
Winfrey C; Wortman S; Frede S; Kunze N; Conrad WF; Heaton PC
J Am Pharm Assoc (2003); 2011; 51(3):373-7. PubMed ID: 21555289
[TBL] [Abstract][Full Text] [Related]
3. Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies.
Johnson JF; Koenigsfeld C; Hughell L; Parsa RA; Bravard S
J Am Pharm Assoc (2003); 2008; 48(3):379-87. PubMed ID: 18595823
[TBL] [Abstract][Full Text] [Related]
4. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
Goode JV; Swiger K; Bluml BM
J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
[TBL] [Abstract][Full Text] [Related]
5. Depression screenings: developing a model for use in a community pharmacy.
Hare SK; Kraenow K
J Am Pharm Assoc (2003); 2008; 48(1):46-51. PubMed ID: 18192130
[TBL] [Abstract][Full Text] [Related]
6. A feasibility study of community pharmacists performing depression screening services.
O'Reilly CL; Wong E; Chen TF
Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
[TBL] [Abstract][Full Text] [Related]
7. Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia.
Fuller JM; Wong KK; Krass I; Grunstein R; Saini B
Patient Educ Couns; 2011 Jun; 83(3):325-35. PubMed ID: 21640541
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting.
Fuller L; Conrad WF; Heaton PC; Panos R; Eschenbacher W; Frede SM
J Am Pharm Assoc (2003); 2012; 52(5):e59-66. PubMed ID: 22975798
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population.
Wilson C; Twigg G
J Am Pharm Assoc (2003); 2018; 58(2):205-209. PubMed ID: 29217142
[TBL] [Abstract][Full Text] [Related]
10. Depression screening in adults by pharmacists in the community: a systematic review.
Miller P; Newby D; Walkom E; Schneider J; Li SC
Int J Pharm Pract; 2020 Oct; 28(5):428-440. PubMed ID: 32776433
[TBL] [Abstract][Full Text] [Related]
11. Physician actions following a positive PHQ-2: implications for the implementation of depression screening in family medicine practice.
Fuchs CH; Haradhvala N; Hubley S; Nash JM; Keller MB; Ashley D; Weisberg RB; Uebelacker LA
Fam Syst Health; 2015 Mar; 33(1):18-27. PubMed ID: 25485822
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
13. Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item.
Corson K; Gerrity MS; Dobscha SK
Am J Manag Care; 2004 Nov; 10(11 Pt 2):839-45. PubMed ID: 15609737
[TBL] [Abstract][Full Text] [Related]
14. Depression Screening and Behavioral Health Integration in Musculoskeletal Trauma Care.
Secrist E; Wally MK; Yu Z; Castro M; Seymour RB; Hsu JR;
J Orthop Trauma; 2022 Sep; 36(9):e362-e368. PubMed ID: 35981227
[TBL] [Abstract][Full Text] [Related]
15. The 12-Month Incidence and Predictors of PHQ-9-Screened Depressive Symptoms in Chinese Primary Care Patients.
Chin WY; Wan EY; Choi EP; Chan KT; Lam CL
Ann Fam Med; 2016; 14(1):47-53. PubMed ID: 26755783
[TBL] [Abstract][Full Text] [Related]
16. Universal depression screening, diagnosis, management, and outcomes at a student-run free clinic.
Soltani M; Smith S; Beck E; Johnson M
Acad Psychiatry; 2015 Jun; 39(3):259-66. PubMed ID: 25491760
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention.
Reid S; Nichols R; Veach S; Alhersh E; Witry M
J Am Pharm Assoc (2003); 2024; 64(3):102067. PubMed ID: 38490332
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a vaccine screening program at an independent community pharmacy.
Rhodes LA; Branham AR; Dalton EE; Moose JS; Marciniak MW
J Am Pharm Assoc (2003); 2017; 57(2):222-228. PubMed ID: 27964886
[TBL] [Abstract][Full Text] [Related]
19. Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents.
Liu Y; Mentele LJ; McDonough RP; Carruthers KM; Doucette WR
J Am Pharm Assoc (2003); 2008; 48(4):515-7. PubMed ID: 18653428
[TBL] [Abstract][Full Text] [Related]
20. Experience with a colorectal cancer campaign in Swiss pharmacies.
Ruggli M; Stebler D; Gasteiger M; Trottmann M; Hochuli P; Telser H; Vaucher F
Int J Clin Pharm; 2019 Oct; 41(5):1359-1364. PubMed ID: 31564044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
